http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1599165-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e95156255d5fe8b2923c544786e176 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K6-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate | 2004-02-10^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71cadba8b0eb0a3a29d9a540b0201f21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccca62b340f1d3467d4d904d5b51f18b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44acf93876120b943e24f6c44ea0597a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6b8b97746b60048459e4cf10aea254c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a73be48f70a94e4d3c923706940b8965 |
| publicationDate | 2005-11-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1599165-A2 |
| titleOfInvention | The use of gcc ligands |
| abstract | Methods of inhibiting the proliferation of colorectal, gastric and esophageal cancer cells in an individual are disclosed. The methods comprise administering to an individual a sufficient amount of ST receptor ligand in a manner such that the proliferation of such cells is inhibited. Enhanced methods of treating an individual who has metastasized colorectal or primary or metastatic gastric or esophageal cancer are disclosed. Methods of increasing the number of ST receptor molecules on the surface of a colorectal cell in an individual are disclosed. The methods comprise administering to an individual an ST receptor ligand in a manner such that the ST receptor ligand comes into contact with an ST receptor on the surface of the colorectal cell in the individual. Methods of increasing the number of ST receptor molecules on the surface of a metastasized colorectal cancer cell in an individual who has metastasized colorectal cancer are disclosed. The methods comprise the step of administering to the individual an ST receptor ligand. Pharmaceutical compositions that comprise sterile, pyrogen free ST receptor ligand and a pharmaceutically acceptable carrier or diluent are disclosed. Methods of treating an individual who has metastasized colorectal cancer are disclosed. The methods comprise the steps of increasing the number of ST receptor molecules on the surface of a metastasized colorectal cancer cell in the individual and then administering a therapeutic pharmaceutical composition that comprises components which target ST receptor for delivery of a therapeutic agent to the individual. Methods of imaging a metastasized colorectal tumor in an individual who has metastasized colorectal cancer are disclosed. The methods comprise the steps of increasing the number of ST receptor molecules on the surface of a metastasized colorectal cancer cell in the individual and then administering an pharmaceutical imaging composition that comprises components which target ST receptor for delivery of an imaging agent. Methods of determining whether an individual has metastasized colorectal cancer are disclosed. Methods of delivering an active compound to a colorectal cell in an individual are disclosed. |
| priorityDate | 2003-02-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 464 of 464.